Inotuzumab Ozogamicin and Chemotherapy in Treating Patients With Leukemia or Lymphoma Undergoing Stem Cell Transplantation
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Thomas Jefferson University
National Cancer Institute (NCI)
Allogene Therapeutics
Massachusetts General Hospital
University of Chicago
Dana-Farber Cancer Institute
Merck Sharp & Dohme LLC
Alliance for Clinical Trials in Oncology
University of Wisconsin, Madison
M.D. Anderson Cancer Center
Acerta Pharma BV
H. Lee Moffitt Cancer Center and Research Institute
National Cancer Institute (NCI)
Case Comprehensive Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Weill Medical College of Cornell University
Institut Bergonié
Incyte Corporation
Washington University School of Medicine
Incyte Corporation
National Institutes of Health Clinical Center (CC)
SWOG Cancer Research Network
City of Hope Medical Center
Massachusetts General Hospital
Thomas Jefferson University
Thomas Jefferson University